FDA Approves Unknown Drug — AUROBINDO PHARMA LTD

# FDA Approves Generic Drug Application for Aurobindo Pharma Aurobindo Pharma Ltd. received FDA approval for ANDA215971 on December 26, 2024, expanding its generic pharmaceutical portfolio and positioning the company to capture additional market share in the competitive U.S. generic drug sector. The approval strengthens Aurobindo's ability to address unmet patient needs while enhancing its revenue potential in key therapeutic categories.